Pluslife
Latest round
- Series A
Last raised
- Nov 2025
Total raised
- Undisclosed
Investors
- 3
About Pluslife
, Ltd, trading as Pluslife, developing innovative molecular diagnostic products using next-generation gene technologies, providing complete solutions from core protein research and development, molecular detection methodology development, to molecular point-of-care testing (POCT) products. The company specializes in advanced diagnostic solutions through its proprietary RNase Hybridization Assisted Amplification (RHAM) technology, which provides high sensitivity and specificity comparable to laboratory PCR tests. Its flagship products, the MiniDock and Dock Pro 8, are designed for accuracy akin to quantitative PCR (qPCR) while maintaining user-friendliness similar to rapid diagnostic tests (RDTs). These products are aimed at addressing various infectious diseases, including tuberculosis and sexually transmitted infections, and serve clinical, point-of-care, and public health settings, particularly in regions like Nigeria and other developing nations. The company generates revenue primarily through direct sales of its diagnostic products, including the MiniDock and Dock Pro 8, targeting healthcare providers, laboratories, and public health initiatives. The company has established partnerships with organizations such as the Gates Foundation to enhance distribution and recognition in public health procurement systems. Revenue is bolstered through bulk orders from healthcare institutions and government agencies seeking effective diagnostic solutions.
Who invested in Pluslife
3 investors across 1 round
See all investors in Pluslife
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Nov 17, 2025
Amount
Undisclosed
Investors
Questions about Pluslife
Who invested in Pluslife?
Pluslife has 3 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Pluslife raised?
Pluslife has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Pluslife last raise money?
Pluslife's most recent round on record is a Series A, in Nov 2025.
What does Pluslife do?
, Ltd, trading as Pluslife, developing innovative molecular diagnostic products using next-generation gene technologies, providing complete solutions from core protein research and development, molecular detection methodology development, to molecular point-of-care testing (POCT) products.
Where is Pluslife headquartered?
Pluslife is headquartered in Guangzhou, China.
Which VCs invest in companies like Pluslife?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back medical devices & equipment companies at Pluslife's stage. Their profiles are linked below.
VCs backing medical devices & equipment startups at Series A
Raising like Pluslife? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.